CYRX
CYRX
NASDAQ · Life Sciences Tools & Services

Cryoport Inc

$17.43
+0.07 (+0.40%)
As of Oct 3, 2:07 AM ET ·
Financial Highlights (FY 2026)
Revenue
179.44M
Net Income
79.75M
Gross Margin
47.1%
Profit Margin
44.4%
Rev Growth
-9.5%
D/E Ratio
0.37
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 47.1% 47.1% 39.0% 39.0%
Operating Margin -20.9% -18.8% 22.9% 18.0%
Profit Margin 44.4% 42.2% 14.0% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 179.44M 198.16M 137.31M 144.41M
Gross Profit 84.59M 93.41M 53.62M 56.39M
Operating Income -37,484,136 -37,256,457 31.39M 25.95M
Net Income 79.75M 79.27M 19.23M 25.18M
Gross Margin 47.1% 47.1% 39.0% 39.0%
Operating Margin -20.9% -18.8% 22.9% 18.0%
Profit Margin 44.4% 42.2% 14.0% 17.4%
Rev Growth -9.5% -9.5% +13.1% +7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 120.74M 120.74M 221.73M 216.61M
Total Equity 323.70M 323.70M 262.41M 301.43M
D/E Ratio 0.37 0.37 0.84 0.72
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -9,261,202 -9,716,335 43.82M 47.91M
Free Cash Flow — — 11.97M 10.29M